[1]
Dr.Vivekananda Chood O.M, Dr.Sriram.K and Dr.Thilagar 2022. Prospective Study to Ascertain the Advantages of Adding Neprilysin Inhibitor to Standard Care Among Patients with Congestive Cardiac Failure. Innovative Journal of Medical and Health Sciences. 12, 05 (May 2022), 1903–1909.